PNEUMOSTEM®, cord blood-derived mesenchymal stem cells for bronchopulmonary dysplasia

PNEUMOSTEM® is an umbilical cord-derived mesenchymal stem cell product intended to treat bronchopulmonary dysplasia in premature infants. The main purpose of this study is to evaluate the safety and the tolerability of PNEUMOSTEM® and to establish the maximum toxicity dose.